Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Selley

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
Brain Research|January 23, 1997
Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatmentD E Selley, E J Nestler, C S Breivogel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 29, 2018
Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in ratsAmy R Johnson, Matthew L Banks, Dana E Selley, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 15, 1996
Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brainL J Sim, D E Selley, S I Dworkin, et al.
European Journal of Pharmacology|July 3, 2007
Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptorsPaul A Smith, Dana E Selley, Laura J Sim-Selley, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studiesGuo Li, Lindsey C K Aschenbach, Hengjun He, et al.
Psychopharmacology|September 3, 2014
Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in ratsAhmad A Altarifi, Yunyun Yuan, Yan Zhang, et al.
Journal of Sports Sciences|June 1, 1995
The relationship between critical power and running performanceT Kolbe, S C Dennis, E Selley, et al.
Molecular Pharmacology|August 3, 2004
Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellumDana E Selley, Michael P Cassidy, Billy R Martin, et al.
Molecular Pharmacology|January 1, 1997
mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacyD E Selley, L J Sim, R Xiao, et al.
Cellular Signalling|December 3, 2014
Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cellsLawrence C Blume, Khalil Eldeeb, Caroline E Bass, et al.
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
Brain Research|January 23, 1997
Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatmentD E Selley, E J Nestler, C S Breivogel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 29, 2018
Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in ratsAmy R Johnson, Matthew L Banks, Dana E Selley, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 15, 1996
Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brainL J Sim, D E Selley, S I Dworkin, et al.
European Journal of Pharmacology|July 3, 2007
Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptorsPaul A Smith, Dana E Selley, Laura J Sim-Selley, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2009
14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studiesGuo Li, Lindsey C K Aschenbach, Hengjun He, et al.
Psychopharmacology|September 3, 2014
Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in ratsAhmad A Altarifi, Yunyun Yuan, Yan Zhang, et al.
Journal of Sports Sciences|June 1, 1995
The relationship between critical power and running performanceT Kolbe, S C Dennis, E Selley, et al.
Molecular Pharmacology|August 3, 2004
Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellumDana E Selley, Michael P Cassidy, Billy R Martin, et al.
Molecular Pharmacology|January 1, 1997
mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacyD E Selley, L J Sim, R Xiao, et al.
Cellular Signalling|December 3, 2014
Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cellsLawrence C Blume, Khalil Eldeeb, Caroline E Bass, et al.
Pageof 15